Invests in
Locations:
Min Investment:
$1,500,000.00Max Investment:
$5,000,000.00Target Investment:
$3,250,000.00
Skills
Education
Lists including Shahram
Investments
Halo Labs
Total Funding: $26M
Ride Health
Total Funding: $6M
Bainbridge Health
Total Funding: $2M
Oncora Medical
Total Funding: $4M
Genome Profiling
Total Funding: $880K
WellTrackONE
Total Funding: $2.2M
TalexMedical
Total Funding: $500K
Keriton Inc
Total Funding: $1M
Cohero Health
Total Funding: $15M
Enzium
Total Funding: $750K
Noble.MD
Total Funding: $1M
Allevi
Total Funding: $3M
HealthQx
Total Funding: $7M
TowerView Health
Total Funding: $200K
InfraScan
Total Funding: $500K
Work Experience
Managing Director & CEO (As of Oct. 2021)
2008
BioAdvance is a 22-year old venture capital firm with over 100 investments. Responsible for the overall leadership and strategic direction of BioAdvance. Lead the investments in digital health, diagnostics and devices. Some of the investments include WellTrackOne Inc., Noble.MD LLC (acquired), HealthQx LLC (acquired), Cohero Health Inc. (acquired), WellSheet Inc., Bainbridge health Inc., Halo Labs Inc., RightAir Inc., Oncora Medical Inc., Talex Medical LLC, Allevi Inc. (acquired), Keriton LLC., CrossBridge, LLC (acquired), and RideHealth Inc.
2014
Faculty and Head of Entrepreneurship
2014
Began as the 2014 James Wei Professor of Entrepreneurship and currently a Faculty and Head of the Entrepreneurship Program, teaching two high-level courses in Entrepreneurship and Venture Capital/Finance of Innovation. The courses which often receive Dean's recognition for Teaching Excellence, are also part of Certificate Programs (minor-degrees) in Entrepreneurship, Finance and Engineering & Society. Lead the development of the Entrepreneurship Curriculum and the Entrepreneurship Program.
2019
Founder and CEO
2019
A venture-backed non-viral gene delivery company based on a transformative polymeric (non-lipid based) platform exclusively licensed from Princeton University.
2008 - 2008
Entrepreneur In Residence
2008 - 2008
2004 - 2008
President
2004 - 2008
President and CEO
2001 - 2004
1996 - 2001
Global Head of Strategic Business Development
1996 - 2001